BrightSpring Health Services, I (BTSG) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

BrightSpring Health Services, I

NasdaqGS•Healthcare•Health Information Services

$60.73-0.70(-0.01%)Pre-market

Market Cap

$11.70B

P/E

32.0x

P/S

0.8x

P/B

5.7x

BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.

How this company scores

ExcellentMetricSide Score: 81/100

Strongest: Cash & Earnings Quality (25/25); weakest: Balance Sheet & Red Flags (15/25).

Profitability18/25

Growth23/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality25/25

Strengths

Growing revenueRising free cash flowHigh ROERising earnings

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 32.0x5y range 27.4x – 72.7x

Currently near its 6-quarter median.

P/S · 0.8x5y range 0.3x – 0.8x

Currently above its 7-quarter median.

P/B · 5.7x5y range 1.2x – 5.7x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

Some Concerns

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.

Share Dilution

Watch

Shares outstanding rose 3.8% — mild dilution. Compare to earnings growth to assess the net per-share impact.

Price & Volume

Market Cap $11.70B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $14.37B
Q. Revenue: $3.87B
TTM EBITDA: $519.60M
TTM Op. Income: $447.80M
Q. Op. Income: $130.39M
TTM Net Income: $365.97M
Q. Net Income: $84.29M
EPS: $0.41
Shares Out.: $206.04M

$14.37B in TTM revenue grew 19.9% YoY, reaching $3.87B last quarter. TTM EBITDA of $519.60M and TTM operating income of $447.80M show growth is flowing through to the bottom line. TTM net income of $365.97M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 12.7%
EBITDA Margin: 3.4%
Op. Margin: 3.4%
Net Margin: 2.2%

Op. margin of 3.4% is up 1.8% YoY — cost efficiency is improving. Net margin at 2.2% and gross margin of 12.7% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 4 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 32.0x
P/S Ratio: 0.8x
P/B Ratio: 5.7x

At 32.0x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 0.8x and P/B of 5.7x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is down 56% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $5.99B
Cash: $550.38M
Long-Term Debt: $2.15B
Book Value: $2.05B
D/E Ratio: 1.0
Debt/EBITDA: 16.5

With $5.99B in assets and $2.15B in long-term debt, D/E is 1.0and book value is $2.05B — moderate leverage. Across the last 8 quarters, debt/equity has fallen for 7 consecutive quarters — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $43.92M
TTM Free Cash Flow: $402.35M
FCF Margin: 2.8%
FCF / Net Income: 1.1

TTM FCF of $402.35M on $43.92M in operating cash flow. The FCF / Net Income ratio of 1.1x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is up 111% — a weakening trend.